**Question:** The diuretic of choice for rapid relief of congestive symptoms in a patient of CHF is:

A. Furosemide
B. Spironolactone
C. Amiodarone
D. Enalapril

**Core Concept:**
In patients with Congestive Heart Failure (CHF), diuretics are commonly used to decrease fluid volume and alleviate congestive symptoms. Diuretics are medications that increase urine production (diuresis) and excrete excess sodium and water, reducing congestion and edema.

**Why the Correct Answer is Right:**
A. Furosemide (Lasix) is a loop diuretic, working on the distal convoluted tubule and collecting duct of the nephron. It enhances the reabsorption of sodium and water, promoting diuresis and natriuresis, thereby reducing congestion and fluid volume in CHF patients.

B. Spironolactone is an aldosterone antagonist, blocking the effects of aldosterone on the distal nephron, leading to decreased sodium and water reabsorption and increased excretion. Although helpful in some cases, it is not as rapid as furosemide for immediate symptom relief.

C. Amiodarone is an antiarrhythmic drug indicated for the treatment of life-threatening ventricular arrhythmias and atrial fibrillation. It is not a first-line choice for acute congestive symptoms in CHF patients due to its potential side effects and slower onset of action.

D. Enalapril is an angiotensin-converting enzyme (ACE) inhibitor, which is used to control chronic heart failure by reducing afterload, preload, and contractility. It is not a rapid option for acute congestive symptoms.

**Why Each Wrong Option is Incorrect:**

A. Amiodarone: Although useful in some cases, its side effects and slower onset of action make it an unsuitable choice for rapid relief of congestive symptoms in CHF patients.

B. Spironolactone: While it is effective, it is not as rapid as furosemide for immediate symptom relief.

C. Enalapril: As an ACE inhibitor, it is not a suitable option for acute congestive symptoms due to its slower onset of action and different mode of action compared to furosemide.

D. Enalapril: Similar to option C, enalapril is an ACE inhibitor, not suitable for rapid symptom relief in CHF patients.

**Clinical Pearls:**

1. Rapid symptom relief in CHF patients requires medications with a faster onset of action, such as loop diuretics (furosemide).
2. Consideration of ACE inhibitors (e.g., enalapril) is for chronic management of heart failure, not acute symptom relief.
3. Spironolactone is also effective for symptom relief, but has a slower onset of action compared to furosemide.
4. Amiodarone has side effects and a slower onset of action, making it unsuitable for acute symptom relief in CHF patients.

In conclusion, f